Scientists test drug cocktail to make ketamine pills possible
NCT ID NCT07462559
Summary
This early-stage study aims to understand how two other drugs—cannabidiol (CBD) and cobicistat—affect how the body processes ketamine when taken by mouth. Researchers will give 12 healthy volunteers a single oral dose of ketamine, sometimes with CBD, cobicistat, or both, to measure drug levels in the blood. The main goal is to see if these other drugs can make oral ketamine more effective and consistent, which could one day lead to new pill-based treatments for depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Department of Clinical Pharmacology
Helsinki, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.